Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Palma-Barqueros V, Revilla N, Zaninetti C, Galera AM, Sanchez-Fuentes A, Zamora-Canovas A, Bohdan N, Padilla J, Marin-Quilez A, Rodriguez-Alen A, Fuster JL, Greinacher A, Vicente V, Bastida JM, Rivera J, Lozano ML. Src-related thrombocytopenia: a fine line between a megakaryocyte dysfunction and an immune-mediated disease. Blood Adv. 2022 Sep 13;6(17):5244-5255. doi: 10.1182/bloodadvances.2021005446. PubMed PMID: 35349645; PubMed Central PMCID: PMC9631645.
AÑO: 2022; IF: 7.5
35349645
Jimenez-Fonseca P, Gallardo E, Arranz Arija F, Blanco JM, Callejo A, Lavin DC, Costa Rivas M, Mosquera J, Rodrigo A, Sanchez Morillas R, Vares Gonzalez M, Munoz A, Carmona-Bayonas A. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence. Eur J Intern Med. 2022 Jun;100:33-45. doi: 10.1016/j.ejim.2022.02.020. Epub 2022 Feb 26. PubMed PMID: 35227541.
AÑO: 2022; IF: 8.0
35227541
Gomez D, Carmona-Bayonas A, Hernandez R, Higuera O, Rogado J, Pacheco-Barcia V, Valero M, Gil-Raga M, Munoz MM, Carrion-Galindo R, Jimenez-Fonseca P, Calderon C. Stoic attitude in patients with cancer from the NEOcoping study: Cross-sectional study. PLoS One. 2022 Jul 28;17(7):e0269712. doi: 10.1371/journal.pone.0269712. eCollection 2022. PubMed PMID: 35901019; PubMed Central PMCID: PMC9333303.
AÑO: 2022; IF: 3.7
35901019
Sancho JM, Marin-Niebla A, Fernandez S, Capote FJ, Canigral C, Grande C, Donato E, Zeberio I, Puerta JM, Rivas A, Perez-Ceballos E, Vale A, Martin Garcia-Sancho A, Salar A, Gonzalez-Barca E, Teruel A, Pastoriza C, Conde-Royo D, Sanchez-Garcia J, Barrenetxea C, Arranz R, Hernandez-Rivas JA, Ramirez MJ, Jimenez A, Rubio-Azpeitia E. IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice. Int J Hematol. 2022 Sep;116(3):381-392. doi: 10.1007/s12185-022-03367-z. Epub 2022 May 13. PubMed PMID: 35551632; PubMed Central PMCID: PMC9392694.
AÑO: 2022; IF: 2.1
35551632
Santaliestra M, Ferrer-Marin F, Alvarez-Larran A; MPN Spanish Group (GEMFIN). Review of the risk of thrombosis or bleeding upon abrupt anagrelide discontinuation in patients with essential thrombocythemia. Ann Hematol. 2022 Nov;101(11):2563-2564. doi: 10.1007/s00277-022-04956-y. Epub 2022 Aug 17. No abstract available. PubMed PMID: 35978180.
AÑO: 2022; IF: 3.5
35978180
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL